Holen Sie sich die Stockscreener-App
0.5767
6.98%
-0.0433
Handel nachbörslich:
.57
-0.0067
-1.16%
Schlusskurs vom Vortag:
$0.62
Offen:
$0.7406
24-Stunden-Volumen:
81,680
Relative Volume:
0.92
Marktkapitalisierung:
$10.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.56M
KGV:
-0.7689
EPS:
-0.75
Netto-Cashflow:
$-22.29M
1W Leistung:
-21.92%
1M Leistung:
-38.89%
6M Leistung:
-82.98%
1J Leistung:
-85.93%
1-Tages-Spanne:
$0.555
$0.7406
1-Wochen-Bereich:
$0.555
$0.7851
52-Wochen-Spanne:
$0.555
$8.55
BiomX Inc Stock (PHGE) Company Profile
Firmenname
BiomX Inc
Sektor
Branche
Telefon
972 7 23942377
Adresse
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Vergleichen Sie PHGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PHGE | 0.5767 | 10.71M | 0 | -26.56M | -22.29M | -0.75 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-15 | Eingeleitet | Ladenburg Thalmann | Buy |
BiomX Inc Aktie (PHGE) Neueste Nachrichten
BiomX Announces Third Quarter 2024 Financial Results and Clinical Program Updates - Defense World
Biomx stock plunges to 52-week low, hits $0.61 - Investing.com India
Biomx stock plunges to 52-week low, hits $0.61 By Investing.com - Investing.com UK
BiomX shares hold Buy rating from H.C. Wainwright on Q3 results - Investing.com Canada
BiomX Inc. (AMEX:PHGE) Q3 2024 Earnings Call Transcript - Insider Monkey
BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net In - GuruFocus.com
BiomX Inc. Reports Q3 2024 Financial Turnaround - TipRanks
BiomX Inc (PHGE) Quarterly 10-Q Report - Quartzy
BiomX Inc (PHGE) Reports Q3 2024 Net Income of $9.6 Million Amid Increased R&D and Administrative Expenses - GuruFocus.com
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates - The Manila Times
BiomX Completes Trial Enrollment, Reports $9.6M Net Income in Q3 Despite Program Delays | PHGE Stock News - StockTitan
BiomX (NYSEMKT:PHGE) Trading 4.6% Higher – Time to Buy? - Defense World
BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024 - GlobeNewswire
Biomx stock plunges to 52-week low of $0.72 amid market challenges By Investing.com - Investing.com South Africa
Biomx stock plunges to 52-week low of $0.72 amid market challenges - Investing.com India
Biomx stock plunges to 52-week low, hits $0.87 - Investing.com India
Biomx stock plunges to 52-week low, hits $0.87 By Investing.com - Investing.com South Africa
BiomX (NYSEMKT:PHGE) Trading Down 2.3%Here's Why - MarketBeat
BiomX announces a mandatory unit separation - MSN
BiomX announces mandatory unit separation - Yahoo Finance
BiomX Announces a Mandatory Unit Separation - The Manila Times
BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ... - Yahoo Finance
BiomX (NYSEAMERICAN:PHGE) Shares Down 1.5% – What’s Next? - Defense World
Biomx stock plunges to 52-week low, hitting $0.92 - Investing.com
Biomx stock plunges to 52-week low, hitting $0.92 By Investing.com - Investing.com South Africa
BiomX (NYSEMKT:PHGE) Stock Price Down 1% - Defense World
BiomX Shares Phage Therapy Advances and Vision - TipRanks
Bacteriophages Therapy Market Size, Share And Growth Analysis - openPR
BiomX Stock Gains From Favorable Study Data Presentation on BX004 - Yahoo Finance
BiomX to present data from Phase 1b/2a study of BX004 - TipRanks
BiomX to Provide Latest Update on Positive Phase 1b/2a - GlobeNewswire
BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference - StockTitan
Biomx stock plunges to 52-week low, hits $1.05 - Investing.com
BiomX (NYSEMKT:PHGE) Trading Down 5.4% - MarketBeat
BiomX (NYSEMKT:PHGE) Shares Down 5.4% - Defense World
Bacteriophage Therapy Market Projected To Witness Substantial Growth, 2024-2031: Enbiotix, Inc., Nextbiotics, - EIN News
BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
PHGEBiomX Inc. Latest Stock News & Market Updates - StockTitan
Biomx stock plunges to 52-week low at $1.15 amid market challenges - Investing.com
BiomX to Present Positive Phase 1b/2a Clinical Trial Data - GlobeNewswire
BiomX to present cinical trial data for BX004 at ERS - TipRanks
BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024 - StockTitan
Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Drops By 92.9% - MarketBeat
BiomX Inc (PHGE) stock analysis: A comprehensive overview - US Post News
Biomx stock plunges to 52-week low at $0.14 amid market challenges - Investing.com
There is no doubt that BiomX Inc (PHGE) ticks all the boxes. - SETE News
PHGE’s 2023 Market Dance: Down -44.29% – Time to Invest? - The InvestChronicle
Balance Sheet Insights: BiomX Inc (PHGE)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
BiomX Inc (PHGE)’s highs and lows: A closer look at its stock price fluctuations - US Post News
BiomX (PHGE) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
BiomX (PHGE) 14-Day RSI : 28.12 (As of Aug. 18, 2024) - GuruFocus.com
Finanzdaten der BiomX Inc-Aktie (PHGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):